KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Deferred Taxes: 2009-2025

Historic Deferred Taxes for Colgate Palmolive (CL) over the last 17 years, with Sep 2025 value amounting to $25.0 million.

  • Colgate Palmolive's Deferred Taxes rose 516.67% to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year increase of 133.33%. This contributed to the annual value of -$77.0 million for FY2024, which is 21.43% up from last year.
  • As of Q3 2025, Colgate Palmolive's Deferred Taxes stood at $25.0 million, which was up 257.14% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Colgate Palmolive's Deferred Taxes ranged from a high of $47.0 million in Q3 2023 and a low of -$136.0 million during Q2 2023.
  • Its 3-year average for Deferred Taxes is -$15.2 million, with a median of $7.0 million in 2025.
  • Examining YoY changes over the last 5 years, Colgate Palmolive's Deferred Taxes showed a top increase of 1,466.67% in 2023 and a maximum decrease of 1,411.11% in 2023.
  • Over the past 5 years, Colgate Palmolive's Deferred Taxes (Quarterly) stood at $14.0 million in 2021, then slumped by 564.29% to -$65.0 million in 2022, then spiked by 116.92% to $11.0 million in 2023, then surged by 90.91% to $21.0 million in 2024, then skyrocketed by 516.67% to $25.0 million in 2025.
  • Its Deferred Taxes stands at $25.0 million for Q3 2025, versus $7.0 million for Q2 2025 and -$24.0 million for Q1 2025.